Gamida Cell Ltd.

NASDAQ:GMDA

0.03 (USD) • At close September 17, 2024
Bedrijfsnaam Gamida Cell Ltd.
Symbool GMDA
Munteenheid USD
Prijs 0.033
Beurswaarde 4,337,295
Dividendpercentage 0%
52-weken bereik 0.03 - 2.51
Industrie Biotechnology
Sector Healthcare
CEO Ms. Abigail L. Jenkins
Website https://www.gamida-cell.com

An error occurred while fetching data.

Over Gamida Cell Ltd.

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in

Vergelijkbare Aandelen

CorMedix Inc. logo

CorMedix Inc.

CRMD

9.99 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.032 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.41 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.19 USD

Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

CUE

1.52 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.

GRPH

3.18 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)